Primary cardiac angiosarcoma presenting as a malignant pericardial effusion

Journal of Clinical Oncology

Volumn 16, Issue 12, 1998, Pages 3913-3915

  Wu, C ^a   Vasconcelles, M ^a   DePiro, P ^a   Van Den Abbeele, A ^a   Rakusin, A ^a   Bechard, K ^a   Skarin, A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; RECOMBINANT INTERLEUKIN 2; TETRACYCLINE DERIVATIVE;

ADVANCED CANCER; AGED; ANGIOSARCOMA; ARTICLE; CANCER SURVIVAL; CASE REPORT; CAUSE OF DEATH; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PARADOXICAL PULSE; PERICARDIAL EFFUSION; PREVALENCE; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0032408015     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.12.3913     Document Type: Article

References (7)

1. Skhvatsabaju LV: Secondary malignant lesions of the heart and percardium in neoplastic disease. Oncology 43:103, 1986
2. Vaitkus PT, Herrmann HC, LeWinter MM: Treatment of malignant pericardial effusion. JAMA 272:59-64, 1994
3. Herrmann MA, Shankerman RA, Edwards WD: Primary cardiac angiosarcoma: A clinicopathologic study of six cases. J Thorac Cardiovasc Surg 103:655-664, 1992
4. Janigan DT, Husain A, Robinson NA: Cardiac angiosarcomas: A review and a case report. Cancer 57:852-859, 1986
5. Nakamichi T, Fukuda T, Suzuki T, et al: Primary cardiac angiosarcoma: 53 months survival after multidisciplinary therapy. Ann Thorac Surg 63:1160-1161, 1997
6. Dichek DA, Holmvang G, Fallon JT, et al: Angiosarcoma of the heart: Three-year survival and follow-up by nuclear magnetic resonance imaging. Am Heart J 115:1323, 1988
7. Crespo MG, Pupon LA, Pradas G, et al: Heart transplantation for cardiac angiosarcoma: Should its indication be questioned? J Heart Lung Transplant 12:527-530, 1993